Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy
Crossref DOI link: https://doi.org/10.1007/s40744-021-00359-z
Published Online: 2021-09-07
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Anjohrin, Suzanne
Sheahan, Anna
Suruki, Robert
Stark, Jeffrey L.
Sloan, Victor S.
Text and Data Mining valid from 2021-09-07
Version of Record valid from 2021-09-07
Article History
Received: 28 June 2021
Accepted: 12 August 2021
First Online: 7 September 2021